Click for next page ( 240

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 239
Appendix C Task Forces TASK FORCE 1 - STRENGTHS ANI) WEAKNESSES OF THE CURRENT SYSTEM Committee Members FI~OYD E. BLOOM (Chair), Chairman, Department of Neuropharmacology, Research Institute of Scripps Clinic, La Jolla, California HENRY J. AARON, Senior Fellow, The Broo~ngs Institution, Washington, D.C. MAUREEN M. HENDERSON, Professor of Epidemiology and Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington DON K PRICE, Professor of Public Management, Emeritus, John F. Kennedy School of Government, Harvard University, Cambridge, Massachusetts HOWARD E. FREEMAN, Professor, Department of Sociology, University of California at Los Angeles, Los Angeles, California 239

OCR for page 239
240 Invited Guests ROBERT W. BERLINER, Professor of Physiology and Medicine, Emeritus, Department of Physiology, Yale University School of Medicine, New Haven, Connecticut APPENDIX C JOEL W. GOLDSTEIN, Deputy Associate Administrator for Extramural Programs & Director, Division of Program Analysis, Alcohol, Drug Abuse and Mental Health Administration, Rockville, Maryland WILLIAM F. DAUB, Deputy Director, National Institutes of Health PETER GREENWALD, Director, Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Maryland TASK FORCE 2 - GOALS OF BIOMEDICAL RESEARCH Committee Members RALPH I. HORWITZ (Chair), Professor, Department of Medicine, Yale University, New Haven, Connecticut MANNA H. GRAY, President and Professor of History, University of Chicago, Chicago, Illinois ERNEST G. JAWORSKI, Distinguished Science Fellow and Director of Biological Sciences, Monsanto Company, St. Louis, Missouri THOMAS W. LANGFI1T, (ex officio member) President and Chief Executive Officer, The Glenmede llust Company and the Pew Charitable [lusts, Philadelphia, Pennsylvania Invited Guest JUDITH RODIN, Phillip R. Allen Professor of Psychology, Professor of Medicine and Psychiatry, Yale University TASK FORCE 3 - OPTIMIZING THE ENVIRONMENT FOR BIOMEDICAL RESEARCH Committee Members KENNETH I. SHINE (Chair), Dean, School of Medicine, University of California at Los Angeles, Los Angeles, California SAMUEL HELLMAN, Dean, Division of Biological Sciences and the Pritzker School of Medicine, and Vice President for the Medical Center, University of Chicago, Chicago, Illinois ARIEL G. LOEWY, Jack and Barbara Bush Professor in the Natural Sciences and Chairman, Department of Biology, Haverford College, Haverford, Pennsylvania

OCR for page 239
TASK FORCES 241 P. DENNIS SMITH, Chairman, Department of Biological Sciences, Wayne State University, Detroit, Michigan JACK D. BARCHAS, Associate Dean for Neuroscience and Professor of Neuroscience and Biobehavioral Sciences, School of Medicine, University of California at Los Angeles, Los Angeles, California Invited Guests IVAN Lo BENNETT, Professor of Medicine, New York University Medical Center, New York, New York TONY MERRITT, Office of Grants and Contracts, University of Pennsylvania, Philadelphia, Pennsylvania